Catalog No.
YVV03401
Expression system
E. coli
Species
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Protein length
Met1-Val22
Predicted molecular weight
18.16 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P0DTF1
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
ORF3b protein, ORF3b
Induction of the Inflammasome by the SARS-CoV-2 Accessory Protein ORF9b, Abrogated by Small-Molecule ORF9b Homodimerization Inhibitors., PMID:39902616
Involvement of SARS-CoV-2 accessory proteins in immunopathogenesis., PMID:38837257
Computational investigation of the inhibitory interaction of IRF3 and SARS-CoV-2 accessory protein ORF3b., PMID:38640732
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population., PMID:36652990
The role of SARS-CoV-2 accessory proteins in immune evasion., PMID:36265309
Roles and functions of SARS-CoV-2 proteins in host immune evasion., PMID:36003396
Development of Monoclonal Antibodies to Detect for SARS-CoV-2 Proteins., PMID:35405107
Genomic evolution of the Coronaviridae family., PMID:35398776
Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients., PMID:35116173
Target genes used for biosensor development in COVID-19 diagnosis., PMID:34974265
Production of Proteins of the SARS-CoV-2 Proteome for Drug Discovery., PMID:34337272
SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns., PMID:34305949
Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins., PMID:34242574
Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo., PMID:34157321
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis., PMID:33980688
Systematizing the genomic order and relatedness in the open reading frames (ORFs) of the coronaviruses., PMID:33848683
Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution., PMID:33774510
Unification and extensive diversification of M/Orf3-related ion channel proteins in coronaviruses and other nidoviruses., PMID:33692906
Protein sequence models for prediction and comparative analysis of the SARS-CoV-2 -human interactome., PMID:33691013
The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children., PMID:33655259
Loss of orf3b in the circulating SARS-CoV-2 strains., PMID:33205709
Unification of the M/ORF3-related proteins points to a diversified role for ion conductance in pathogenesis of coronaviruses and other nidoviruses., PMID:33200132
SARS-CoV-2-specific virulence factors in COVID-19., PMID:33085084
Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic., PMID:33001029
SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant., PMID:32941788
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV., PMID:32938761
Characterization of accessory genes in coronavirus genomes., PMID:32854725
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection., PMID:32807944
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan., PMID:31987001
For research use only. Not for human or drug use.
